Andreas Halvorsen: portfolio of Viking Global Investors

Andreas Halvorsen leads Viking Global Investors, a hedge fund that analyzes stocks worldwide and combines long and short positions.

Source: 13F filing with the US Securities and Exchange Commission dated May 15, 2026. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included.

You are looking at Q1 2026. Go to the latest filing (Q3 2026)

35.7B USDQ1 2026
Total value of stock positions
35.7B USD
Positions
77
Share of the ten largest
34.9%

The ten largest positions Q1 2026

  1. Visa Inc. 5.4%▲ +58.8%
  2. Taiwan Semiconductor Manufacturing (ADR) 4.2%▼ −9.2%
  3. Charles Schwab Corporation 3.9%▲ +5.7%
  4. Walt Disney Company (The) 3.6%▲ +18.8%
  5. Fortive 3.5%▲ +16.9%
  6. Air Products 3.3%▼ −14.2%
  7. Mcdonalds Corp 3.2%▲ +0.2%
  8. Sherwin-Williams 2.8%▼ −1.9%
  9. Tesla, Inc. 2.6%▲ +46.7%
  10. Apple Inc. 2.6%new
Total value of stock positions per quarter, Q2 2013 to Q3 2026 (peak 38.5B USD).
Choose a quarter (54 filings)

All positions Q1 2026

Positions Q1 2026 per 13F filing, 77 of 77
Symbol Weight Shares Reported value Change Held since
V Visa Inc. 5.4% 6,328,185 1.9B USD +58.8% increased Q3 2024 7 quarters
TSM Taiwan Semiconductor Manufacturing (ADR) 4.2% 4,465,127 1.5B USD −9.2% reduced Q4 2024 6 quarters
SCHW Charles Schwab Corporation 3.9% 14,664,954 1.4B USD +5.7% increased Q3 2024 7 quarters
DIS Walt Disney Company (The) 3.6% 13,298,462 1.3B USD +18.8% increased Q2 2025 4 quarters
FTV Fortive 3.5% 22,479,388 1.2B USD +16.9% increased Q3 2019 27 quarters
APD Air Products 3.3% 4,104,095 1.2B USD −14.2% reduced Q2 2025 4 quarters
Mcdonalds Corp 3.2% 3,625,029 1.1B USD +0.2% increased Q1 2025 5 quarters
SHW Sherwin-Williams 2.8% 3,112,767 997.8M USD −1.9% reduced Q2 2024 8 quarters
TSLA Tesla, Inc. 2.6% 2,493,561 927.0M USD +46.7% increased Q1 2025 5 quarters
AAPL Apple Inc. 2.6% 3,593,057 911.9M USD new Q1 2026 1 quarter
Bridgebio Pharma Inc 2.5% 11,842,434 879.4M USD −17.7% reduced Q2 2019 28 quarters
CVNA Carvana 2.4% 2,780,035 874.0M USD +161.9% increased Q2 2024 8 quarters
MSFT Microsoft 2.4% 2,309,446 854.9M USD −28.2% reduced Q3 2025 3 quarters
TMO Thermo Fisher Scientific 2.3% 1,668,025 819.9M USD +110.3% increased Q4 2025 2 quarters
JPM JPMorgan Chase 2.2% 2,704,018 795.4M USD +41.9% increased Q2 2024 8 quarters
CSX CSX Corporation 2.1% 18,678,052 766.7M USD +35.2% increased Q4 2022 14 quarters
ICE Intercontinental Exchange 2.1% 4,836,896 760.7M USD +0.7% increased Q4 2025 2 quarters
LII Lennox International 2.0% 1,572,419 729.8M USD +153.1% increased Q4 2025 2 quarters
GOOGL Alphabet Inc. (Class A) 1.9% 2,395,865 689.0M USD −10.1% reduced Q4 2025 2 quarters
FDX FedEx 1.9% 1,932,165 688.2M USD new Q1 2026 1 quarter
GM General Motors 1.9% 9,176,943 683.7M USD +34.8% increased Q4 2024 6 quarters
BA Boeing 1.8% 3,196,041 636.1M USD −19.2% reduced Q4 2024 6 quarters
PNC PNC Financial Services 1.8% 3,027,092 629.9M USD −58.5% reduced Q2 2025 4 quarters
TMUS T-Mobile US 1.7% 2,967,374 623.2M USD −21.0% reduced Q4 2023 10 quarters
META Meta Platforms 1.7% 1,062,575 607.9M USD new Q1 2026 1 quarter
Regal Rexnord Corporation 1.6% 3,142,851 588.5M USD −2.5% reduced Q4 2023 10 quarters
MAA Mid-America Apartment Communities 1.6% 4,798,404 586.0M USD +23.7% increased Q3 2025 3 quarters
JCI Johnson Controls 1.6% 4,419,923 578.8M USD −25.3% reduced Q2 2025 4 quarters
Medline Inc 1.4% 11,433,992 508.8M USD +64.3% increased Q4 2025 2 quarters
HCA HCA Healthcare 1.4% 1,075,133 508.8M USD +7.6% increased Q4 2023 10 quarters
Ati Inc 1.4% 3,332,843 484.8M USD new Q1 2026 1 quarter
Celestica Inc 1.3% 1,654,989 466.2M USD −2.6% reduced Q3 2025 3 quarters
CPT Camden Property Trust 1.3% 4,715,394 460.5M USD −1.0% reduced Q1 2024 9 quarters
CB Chubb Limited 1.2% 1,295,011 422.1M USD +27.7% increased Q4 2025 2 quarters
Adaptive Biotechnologies Cor 1.2% 29,993,708 416.3M USD unchanged Q2 2019 28 quarters
Biomarin Pharmaceutical Inc 1.1% 7,062,077 398.9M USD +17.0% increased Q4 2021 18 quarters
SE Sea Limited (ADR) 1.1% 4,737,196 392.3M USD +29.0% increased Q1 2025 5 quarters
WAT Waters Corporation 1.0% 1,256,462 374.2M USD new Q1 2026 1 quarter
CCL Carnival Corporation 1.0% 13,721,348 355.1M USD −2.4% reduced Q4 2025 2 quarters
AON Aon plc 1.0% 1,087,114 350.9M USD +38.7% increased Q3 2025 3 quarters
HAS Hasbro 1.0% 3,738,902 350.0M USD new Q1 2026 1 quarter
RDDT Reddit 1.0% 2,551,617 343.6M USD new Q1 2026 1 quarter
PGR Progressive Corporation 0.9% 1,616,559 320.5M USD +21.4% increased Q4 2025 2 quarters
AIG American International Group 0.9% 4,221,223 317.6M USD new Q1 2026 1 quarter
COF Capital One 0.8% 1,612,374 294.1M USD −45.4% reduced Q1 2025 5 quarters
Dicks Sporting Goods Inc 0.7% 1,264,170 250.7M USD −50.9% reduced Q4 2025 2 quarters
AMZN Amazon 0.7% 1,195,428 249.0M USD −61.8% reduced Q4 2025 2 quarters
Amer Sports Inc 0.7% 7,270,476 239.3M USD +51.0% increased Q1 2025 5 quarters
Api Group Corp 0.7% 5,837,000 236.5M USD −49.4% reduced Q2 2020 24 quarters
Tic Solutions Inc 0.7% 35,824,562 235.7M USD +4.3% increased Q1 2025 5 quarters
Cboe Global Mkts Inc 0.5% 688,417 193.5M USD new Q1 2026 1 quarter
Roivant Sciences Ltd 0.5% 6,652,448 184.3M USD +3.2% increased Q4 2021 18 quarters
HD Home Depot (The) 0.5% 504,257 165.8M USD new Q1 2026 1 quarter
Gallagher Arthur J & Co 0.4% 727,441 157.5M USD −30.1% reduced Q4 2025 2 quarters
LULU Lululemon Athletica 0.4% 980,568 150.1M USD new Q1 2026 1 quarter
Newamsterdam Pharma Company 0.4% 4,203,567 134.6M USD unchanged Q4 2022 14 quarters
Oruka Therapeutics Inc 0.4% 2,666,690 130.8M USD unchanged Q3 2025 3 quarters
Sionna Therapeutics Inc 0.4% 3,195,181 128.1M USD unchanged Q1 2025 5 quarters
Stellantis N.v 0.3% 15,980,268 111.9M USD −59.1% reduced Q4 2025 2 quarters
CRWV CoreWeave 0.3% 1,397,438 108.3M USD new Q1 2026 1 quarter
Veradermics Inc 0.3% 1,690,555 106.8M USD new Q1 2026 1 quarter
West Pharmaceutical Svsc Inc 0.3% 416,948 104.5M USD +41.3% increased Q4 2025 2 quarters
Pharvaris N V 0.3% 3,653,310 103.2M USD unchanged Q1 2021 21 quarters
Inhibrx Biosciences Inc 0.3% 1,437,705 96.7M USD unchanged Q2 2024 8 quarters
IBKR Interactive Brokers 0.3% 1,394,329 93.5M USD new Q1 2026 1 quarter
Ralliant Corp 0.2% 2,134,899 88.8M USD −32.5% reduced Q2 2025 4 quarters
EW Edwards Lifesciences 0.2% 1,097,578 87.9M USD new Q1 2026 1 quarter
Oric Pharmaceuticals Inc 0.2% 5,824,533 73.8M USD −11.4% reduced Q1 2024 9 quarters
Damora Therapeutics Inc 0.2% 2,311,082 59.9M USD new Q1 2026 1 quarter
TWLO Twilio 0.2% 450,770 56.7M USD new Q1 2026 1 quarter
Standard Biotools Inc 0.2% 58,651,170 53.9M USD unchanged Q1 2024 9 quarters
Trevi Therapeutics Inc 0.1% 3,198,644 38.2M USD unchanged Q3 2022 15 quarters
Ginkgo Bioworks Holdings Inc < 0.1% 3,577,128 21.9M USD unchanged Q3 2024 7 quarters
Equipmentshare Com Inc < 0.1% 1,000,000 20.4M USD new Q1 2026 1 quarter
Forgent Power Solutions Inc < 0.1% 650,000 19.0M USD new Q1 2026 1 quarter
Pepgen Inc < 0.1% 3,482,434 6.2M USD unchanged Q2 2022 16 quarters
Rallybio Corp < 0.1% 524,347 4.7M USD new Q1 2026 1 quarter

“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.

Breakdown by sector

  • Financials 20.4%
  • Industrials 13.0%
  • Consumer Discretionary 10.5%
  • Communication Services 9.9%
  • Technology 9.6%
  • Materials 6.1%
  • Health Care 5.0%
  • Real Estate 2.9%
  • not in our coverage 22.6%

Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.

How to read this page

  • Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
  • Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
  • Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.

All superinvestor portfolios Screener: stocks held by superinvestors

↑ ↓ select · Enter open · Esc close